Interventional EUS: The World Beyond WON - Part-3 The Evolution of EUS Guided Biliary Drainage - from SEMS to LAMS

Cori Ofstead, CEO of Ofstead & Associates, Inc., and Betty McGinty of Boston Scientific present eye-opening data and examples of the current state of scope reprocessing effectiveness. Viewers will hear how to establish core quality management guidelines for endoscope safety and the prevention of patient infections and exposures. Learn practical solutions for reprocessing effectiveness.

Drs. Massoll and Levine discuss the association between STRs - short tandem repeats, also known as microsatellites -, loss of heterozygosity/allelic imbalance and pancreatic cyst risk stratification. Hear about the expanding role of molecular markers in pancreatic cyst diagnosis. Improve your knowledge of common methods for STR detection and the benefits and challenges associated with each.

Dr. Geri Keane and nurse practitioner Kristen Koller work through how to build an endobariatric program, from patient intake and ESG eligibility screening to insurance authorization, procedure preparation, recovery, and follow-up. The speakers emphasize setting realistic expectations, screening for behavioral and medical concerns, and coordinating care across clinicians, dietitians, behavioral health, and administrative staff. They review evidence for durable weight loss after ESG and highlight frequent follow-up, accessible referral pathways, and regular process reviews as keys to patient and program success.